- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.07. | The observation status for ProstaLund AB is updated | 132 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
Today... ► Artikel lesen | |
| 01.07. | The observation status for ProstaLund AB is updated | 117 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On May... ► Artikel lesen | |
| 30.05. | ProstaLund AB: ProstaLund AB - Interim report January-March 2025 | 92 | GlobeNewswire (Europe) | Januari 1 - March 31Net sales reached SEK 3,7 million (3,5)Operating result amounted to -5,0 MSEK (-4,7)Profit after tax amounted to -5,0 MSEK (-4,8)Earnings per share before and after dilution amounted... ► Artikel lesen | |
| PROSTALUND Aktie jetzt für 0€ handeln | |||||
| 23.05. | XFRA 7PL0: WIEDERAUFNAHME/RESUMPTION | 331 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 23.05. | The observation status for ProstaLund AB is updated | 194 | GlobeNewswire | On May 13, 2025, the shares in ProstaLund AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On May... ► Artikel lesen | |
| 21.05. | Lift of Suspension in ProstaLund AB at FNSE | 159 | GlobeNewswire | 2025-05-21T15:00:36Z
Lifting of Suspension
At Trading Venue FNSE
Ended on:
2025-05-21T14:50:00Z
Ongoing: False
Comments: Nasdaq Stockholm has, to the
extent applicable, also decided to lift the suspension... ► Artikel lesen | |
| 20.05. | ProstaLund AB: First patients treated with CoreTherm Eagle | 185 | GlobeNewswire (Europe) | The first patients with benign prostatic hyperplasia have been successfully treated using our new CoreTherm® Eagle platform.
"We are very pleased that the first patients have been successfully treated... ► Artikel lesen | |
| 19.05. | XFRA 7PL0: AUSSETZUNG/SUSPENSION | 136 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPROSTALUND AB 7PL0... ► Artikel lesen | |
| 19.05. | Suspension of Trading in ProstaLund AB at FNSE | 170 | GlobeNewswire | 2025-05-19T07:01:39Z
Suspension
At Trading Venue FNSE
Due to Other
Ongoing:
True
Comments: Nasdaq Stockholm has, to the extent applicable, also decided to
suspend the trading in all other instruments... ► Artikel lesen | |
| 20.02. | ProstaLund AB: ProstaLund AB - Year-end report 2024 | 115 | GlobeNewswire (Europe) | "With several ongoing contract discussions for CoreTherm® Eagle, we are positive about the interest in our treatment and the upcoming international launch"
Fourth quarterOctober 1 - December 31Net sales... ► Artikel lesen | |
| 14.02. | ProstaLund AB: New study confirms the strong efficacy of CoreTherm in patients with large prostates | 206 | GlobeNewswire (Europe) | A newly published Danish study has evaluated the efficacy and safety of CoreTherm® in men with prostate sizes exceeding 100 grams. The median prostate size among participants was 126 g (range: 101-230... ► Artikel lesen | |
| 23.12.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 23.12.2024 | 497 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.12.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.12.2024
Aktien
1 US67090S1087 Nuveen Churchill Direct... ► Artikel lesen | |
| 20.12.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.12.2024 | 444 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 20.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.12.2024ISIN NameBMG1961Q3325 CATCO... ► Artikel lesen | |
| 20.12.24 | XFRA ISIN CHANGE | 347 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenSE0002372318 ProstaLund AB 20.12.2024 SE0023468418 ProstaLund AB 23.12.2024 Tausch 40:1 ► Artikel lesen | |
| 20.12.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.12.2024 | 489 | Xetra Newsboard | Das Instrument VSL AU000000DCC9 DIGITALX LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 20.12.2024 und ex Kapitalmassnahme am 23.12.2024 The instrument VSL AU000000DCC9 DIGITALX LTD. EQUITY is traded... ► Artikel lesen | |
| 18.12.24 | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for ProstaLund AB | 203 | GlobeNewswire | Referring to the press release from ProstaLund AB's from December 17, the company will carry out a reverse stock split in relations 1:40. The share will be traded under new ISIN code with effect... ► Artikel lesen | |
| 07.11.24 | ProstaLund AB: Interim report January-September 2024 | 149 | GlobeNewswire (Europe) | "With the first ten CoreTherm® Eagle machines manufactured, we see great opportunities to provide more clinics, both in the Nordic region and internationally, with the possibility to offer an effective... ► Artikel lesen | |
| 19.08.24 | ProstaLund AB: ProstaLund AB - Interim report January-June 2024 | 141 | GlobeNewswire (Europe) | ProstaLund is on a good track to establish CoreTherm® internationally again
Second quarterApril 1 - June 30Net sales reached SEK 2,8 (5,3) millionOperating profit/loss totaled SEK -7,2 million (-4,0)... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 49,490 | +1,98 % | Chinas Griff nach dem Rohstoffmarkt wackelt - und dieses Unternehmen steht bereit, die Lücke zu füllen! | ||
| FRESENIUS | 42,460 | +0,38 % | Fresenius Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| FRESENIUS MEDICAL CARE | 44,980 | -0,62 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius Medical Care (FMC) mit einem Kursziel von 41,50 Euro auf "Underweight" belassen. David Adlington glich seine Prognosen... ► Artikel lesen | |
| GERRESHEIMER | 44,840 | -2,73 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
28.07.2025 / 11:35 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| GENEDX | 103,57 | 0,00 % | Why GeneDx Holdings Stock Crushed It Again Today | ||
| CARL ZEISS MEDITEC | 50,05 | -2,15 % | Carl Zeiss Meditec Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| ALIGNMENT HEALTHCARE | 13,045 | 0,00 % | Alignment Healthcare GAAP EPS of $0.07 beats by $0.14, revenue of $1B beats by $39.49M | ||
| BRIGHTSPRING HEALTH SERVICES | 21,320 | +6,07 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 51,37 | -4,59 % | PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO | Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing... ► Artikel lesen | |
| BIONEXUS GENE LAB | 7,250 | 0,00 % | BioNexus Gene Lab Corp - 8-K, Current Report | ||
| ATRICURE | 35,110 | 0,00 % | AtriCure, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| INCANNEX HEALTHCARE | 0,844 | 0,00 % | Pre-market Movers: Linkhome, Eightco Holdings, Incannex Healthcare, Coursera, NextCure | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.35 A.M. ET).In the Green Linkhome Holdings Inc. (LHAI) is up over 120% at $12.40.
Eightco... ► Artikel lesen | |
| LIFEMD | 10,090 | 0,00 % | LifeMD, Inc.: LifeMD to Report Second Quarter 2025 Financial Results on August 5 | ||
| BETA BIONICS | 16,760 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| ECKERT & ZIEGLER | 67,00 | -1,25 % | EQS-NVR: Eckert & Ziegler SE: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Gesamtstimmrechtsmitteilung: Eckert & Ziegler SE
/ Veröffentlichung der Gesamtzahl der Stimmrechte
Eckert & Ziegler SE: Veröffentlichung der Gesamtzahl der Stimmrechte nach... ► Artikel lesen |
Das Unternehmen PROSTALUND AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,001 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROSTALUND AB finden Sie auf Wallstreet Online.